Ryan's Quest Advisory Board

Executive Board


David Schultz – Co-Founder & Ryan’s Dad


Vice President

Maria Schultz – Co-Founder & Ryan’s Mom


Chairman of the Board

Jeannine Cimino – Berkshire Bank


Vice-Chairman of the Board

Matthew Candelori – Kramer Beverage


Andrea Meier – AAA Mid-Atlantic



Linda Ialacci – Linda Ialacci CPA, LLC


Legal Counsel

Crivelli & Barbati – Hamilton NJ

Board of Directors

​Jessie Armstead – NY GIANTS & Hamilton Honda

Chris Cline – GEICO Hamilton

Justin Coecliff – Bank of America Merrill Lynch

Stacy Cucchiaro – Investors Bank

Tracey Destribats – Trenton Catholic Academy

Brian Klabbatz – Pennsylvania Steel Co., Inc.

Norman Koenigsberg - First Choice Loan Services 
Pat Locane – State of New Jersey

Kevin Manna – Jersey Mike's

Joseph Vasta - JET Electric Testing, LLC

Lisa Schaible  – Investors Bank

Nina Melker – Berkshire Bank

Denise Powers – Berkshire Bank
John Rossi – Arora & Associates, PC

Bill Rue Jr. – Rue Insurance

Michael A. Sabo – Pulse Media

Michael Saporito – Hamilton Honda

Andrew Sklarz – CURE Insurance Arena

Benny Tramo – Bloomberg LP

Cory Zeiter – Mixbin

Scientific Advisors

Carlo Rago, PhD

Johns Hopkins

Dr. Rago received his PhD in Cellular and Molecular Medicine from the Johns Hopkins School of Medicine.  He was a recipient of the Ruth L. Kirschstein National Research Service Award, continuing his work in the Ludwig Center for Cancer Genetics and Therapeutics at Johns Hopkins as a post-doctoral fellow in the Vogelstein lab.  He co-authored over 30 papers in high-profile journals and helped co-develop a comprehensive genetic test for Duchenne muscular dystrophy.  He has also participated in discussions at the Food and Drug Administration (FDA) to help develop a framework to understand patient perspectives and help define "permissible risk" for clinical trial regulatory decisions.  He also formally lobbied the FDA to include DMD in PDUFA-V.


Dr. Rago was the recipient of the Ryan's Quest HERO award in 2012 and has been invited to speak around the world to promote transparency, collaboration, and biomedical progress.  

Joshua Selsby, PhD

Iowa State University